Area of research
Otorhinolaryngology · Radiation
Research interest
Research focused on Cetuximab and SABR volatility model, with related work in KRAS, Adverse effect, Randomized controlled trial. Notable publications include 'Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer', 'The KRAS -Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer', and 'Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study'.
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
The <i>KRAS</i>-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study